Methods are introduced and illustrated for synthesizing evidence from case-control and cohort studies and controlled trials, accounting for differences among the studies in their design, length of follow-up, and quality. The methods, based on hierarchical but nonexchangeable Bayesian models, are illustrated in a synthesis of disparate information about the health effects of passive exposure to environmental tobacco smoke.
Introduction
The hazards of combining evidence naïvely from multiple sources are well known. Even among sources intended to be homogeneous, such as multicenter controlled medical trials, there will be some variation in patient attributes and treatment regimens. This variation is strongly exacerbated in epidemiological studies because of differing study designs and methods and differing population characteristics: designs may vary according to their retrospective or prospective nature, their case-control, cohort, or cross-sectional structure, length of followup, admission and classification criteria, control of biases, consideration of confounders, and data collection procedures. Study populations will vary in their age structure, diet and other lifestyle factors, genetic makeup, and environmental exposure to competing and contributing risks. Investigators also vary with respect to experience, motivation and skill. All of these issues will threaten the validity of methods which simply pool the data. Methods which are sensitive to the probability distributions governing the individual studies' observed outcomes can make more complete use of study information and so can lead to more powerful statistical tests and to shorter credible intervals for uncertain parameters.
Beginning with Fisher's (1934) early attempt to avoid the problem of heterogeneity in field trials by combining individual p-values to assess the overall significance level, a number of authors have introduced novel statistical methods intended to quantify an overall "effect size" and assess its variation. These methods, referred to collectively as meta-analysis, are described and compared by many authors including Hedges and Olkin (1985) and the National Research Council review (1992) .
More recently Bayesian and Bayesian-inspired methods have been brought to bear on the meta-analysis problem starting with the landmark papers by DuMouchel and Harris (1983) , who introduced the idea of constructing hierarchical Bayesian models to synthesize information from five types of environmental studies of the effect on human and animal subjects of exposure to nine related environmental agents, and Dempster, Selwyn, and Weeks (1983) , who synthesized historical and contemporary clinical evidence. Subsequent authors offered broad guides to the use of Bayesian hierarchical models for synthesizing evidence include Berry (1990) , Carlin (1992) , DuMouchel (1990 DuMouchel ( , 1996 , Higgins and Spiegelhalter (2002) , Liao (1999) , who combined 2×2 tables, Morris and Normand (1992) , Normand (1999) , Smith, Spiegelhalter, and Parmar (1996) , Spiegelhalter, Thomas, Best, and Lunn (2002, in the bugs software examples), and Sutton and Abrams (2001) . All of these approaches make at least some accommodation for study heterogeneity, commonly through inclusion of a single extra variance term in the hierarchical model structure, but each treats all the studies as exchangeable (at least within groups).
In many meta-analytic applications the simplifying assumption of exchangeability (de Finetti, 1930) is simply untenable-studies differ too much in their designs, subject selection criteria, or other details for any analysis that ignores these differences to be convincing. One approach would be to quantify how similar the different studies are to each other (Draper et al., 1993) or how similar they are to the target circumstances, and exclude or discount in ad hoc ways those studies regarded as too dissimilar.
We propose a different approach: the construction of a hierarchical Bayesian model with submodels for each study or other source of evidence, that reflect and accommodate important study-specific differences. In this coherent approach the investigator begins by specifying in detail the target conditions-for example, the subject population, treatment or exposure details, and case or outcome details. Each individual study offers direct evidence through its likelihood function about the parameters that govern that particular study, with its specific design, selection criteria, etc.; we construct an adjusted likelihood function that describes the indirect evidence offered by each study about the questions of interest to the investigator under the specified target conditions. Studies conducted under conditions quite similar to the target conditions will lend strong evidence; studies less similar will lend more uncertain evidence, leading in a natural way for them to be discounted appropriately in an overall synthesis.
Evidence from Individual Studies
Epidemiological studies offer direct evidence about the conditional probabilities of outcome status (for cohort studies) or exposure (for case-control studies) for the study populations and, through these, indirect evidence about the quantity of interest: usually, some measure of the association between exposure and outcome within the entire population. Evidence is often available about the size and impact of varying age distributions, misclassification rates, and other confounding features and possible biases, but this evidence is rarely used in analyses. The methodology we present offers an opportunity to exploit this evidence.
In a cohort study (CHS) subjects are drawn from a specified population and classified as exposed or unexposed (Breslow and Day, 1987) . They are then followed for a specified length of time and classified with respect to their disease status. Such studies may be conducted prospectively or retrospectively. Evidence bears directly on the conditional probabilities of becoming a case, p c|e and p c|ē , in the exposed and unexposed study arms respectively, through the likelihood function (Berger and Wolpert, 1988) ; in the simple case where age and other covariates are not considered this is
where n ce and nc e are the numbers of cases and non-cases among the n e exposed subjects and n cē and ncē are the numbers of cases and non-cases among the nē unexposed subjects, respectively. Occasionally these conditional probabilities may themselves be useful but more often interest lies in some measure of their difference quantifying the association between outcome and exposure, such as the simple difference ε SD = p c|e −p c|ē , log relative risk ε LRR = log(p c|e /p c|ē ), or log odds ratio ε LOR = log(p c|e pc |ē /pc |e p c|ē ).
Each of these measures will be positive if greater exposure is associated with higher levels of disease, zero if they are unrelated, and each can be estimated in a cohort study by its maximum likelihood estimator (MLE) such asε LOR = log(n ce ncē/n cē nc e ). These and other measures have been discussed, illustrated and compared by many authors including Breslow and Day (1980, Ch. 2), Cox (1970 , p. 20), Freeman (1987 and Wolpert (1986) .
A variety of methods (see Berger, Liseo, and Wolpert, 1999) have been proposed for extracting information about a quantity of interest like ε amid nuisance parameters; the Bayesian approach is to select a conditional prior distribution π(dp |ε) for p = (p c|e , p c|ē ) and summarize the evidence about ε alone by
A change of variables to the log odds ratio ε = ε LOR and independent Jeffreys' reference priors for both case probabilities p c|e and p c|ē leads to the likelihood
where 2 F 1 (a, b; c; z) is the confluent hypergeometric function (Abramowitz and Stegun, 1964, p. 558) . With the implied prior π(ε) = ε/2π 2 sinh(ε/2), the log odds ratio ε LOR has posterior mean and variance µ = ψ(n ce + 1/2) − ψ(nc e + 1/2) − ψ(n cē + 1/2) + ψ(ncē + 1/2) ≈ log(n ce ncē / nc e n cē ) (3)
where ψ(z + 1/2) = log z + O(z −2 ) and ψ ′ (z + 1/2) = 1/z + O(z −3 ) are the digamma and trigamma functions (Abramowitz and Stegun, 1964, §6.3,4) .
For example, Fig. 1 shows L CHS (ε) for the famous 1985 extracorporeal membrane oxygenation (ECMO) trial (see Ware, 1989) , in which 6 of 10 subjects survived in the control group and 9 of 9 survived who were "exposed" to ECMO. The solid line is L CHS (ε) from Eqn. (2), the dashed line is 0.1 1 10 100
Odds Ratio R e the marginal prior density function π(ε), and the vertical bar at ε LOR = 0 marks the null effect; the posterior probability of greater risk for ECMO is P[ε LOR > 0] ≈ 0.0107 with this prior (see Kass and Greenhouse (1989) and Lavine, Wasserman, and Wolpert (1991) for discussions of prior distributions for this problem). For less extreme contingency tables, including all of those in the environmental tobacco smoke (ETS) case study considered below, the distribution is very well approximated by a normal with the same mean and variance or with the approximate means and variances given in Eqns. (3-4) above. Similar expressions are available for the other measures of exposure effect in cohort studies.
Similarly, in a case-control study (CCS) some number n c of cases are matched with nc non-cases (controls) on the basis of demographic variables and other covariates (Breslow and Day, 1980) , and then within each of these groups subjects are further classified into those who are exposed (n ce , nc e ) and unexposed (n cē , ncē). Such a study can offer direct evidence only about the conditional probabilities of exposure within case and non-case groups, p e|c and p e|c through the likelihood function
Only indirect evidence is given about the remaining probabilities. Independent reference priors for the unobserved exposure probabilities p e|c , p e|c lead to an adjusted likelihood function
2 F 1 (n c + 1, n e + 1; n + 2; 1 − e ε ), (6) again approximately normal with mean µ ≈ log(n ce ncē / nc e n cē ) and variance σ 2 ≈ 1/n ce + 1/n cē + 1/nc e + 1/ncē.
Exchangeable Combination of Evidence
If study subjects comprise a simple random sample from some population, then both cohort studies and case-control studies give evidence about the same vector θ = (θ ce , θ cē , θc e , θcē) of probabilities that an eligible subject drawn randomly from the target population will be an exposed or unexposed case, exposed or unexposed non-case, respectively, through their respective likelihood functions L CHS (p c|e , p c|ē ) (since p c|e = θ ce /θ e , p c|ē = θ cē /θē) and L CCS (p e|c , p e|c ) (since p e|c = θ ce /θ c , p e|c = θc e /θc), so it is convenient to express all studies' evidence in terms of θ before trying to combine them across study types.
Evidence about a common parameter vector θ may be captured from a set of I independent studies through the joint likelihood function L I (θ) = i∈I L i (θ). For case-control studies, for example, this is equivalent to observing n + ce ≡ i∈I n i ce exposed and n + cē ≡ i∈I n i cē unexposed cases, n + ce ≡ i∈I n ī ce exposed and n + cē ≡ i∈I n ī cē unexposed non-cases in a single pooled study. However, in most cases, the underlying assumption of exactly the same conditional probabilities in all I studies is just not reasonable. The studies almost always differ in important respects that affect their probabilities of exposure and outcome and hence their evidence about θ. The effect of ignoring this variation is systematically to under-represent uncertainty in the posterior distribution, and sometimes to distort the location of the distribution as well.
A first step toward accommodating study variation is to allow the conditional case (resp., exposure) probabilities p c|ē , p c|e (resp., p e|c , p e|c ) to vary across studies, while still treating the measure of interest ε as constant across all studies. Changing variables to ε = ε LOR and p i c|ē for cohort studies and p i e|c for case-control studies leads to
and in each case to L I (ε) = L(ε, p I ) π(d p I |ε) for the evidence about ε-for independent Jeffreys' prior distributions, for example, to
approximately normal again but now with mean µ FE ≈ i∈I µ i σ
, the precision-weighted mean of the sample means µ i ≈ log(n i ce n ī cē / n ī ce n i cē ) using variances σ 2 i ≈ [1/n i ce + 1/n ī ce + 1/n i cē + 1/n ī cē ]. This is the familiar fixed effects model. The best choice of π(dp | ε) will depend on the application; in the example presented in Section 3 both reference and informed prior distributions are illustrated.
While some invariance may be offered by using a measure of exposure effect that is thought to be relatively insensitive to study variation (for example, using ε LOR if the variations are expected to scale incidence odds by equal factors; see Wolpert (1986) ), possible variation across studies in the effect measures ε i should be modeled explicitly. If we take ε i ∼ No(ε, σ 2 ), for example, independent normal variates with common unknown mean ε and known variance σ 2 , and ascribe a diffuse conjugate prior distribution ε ∼ No(µ, τ 2 ), the earlier normal approximations to L CHS (ε LOR ) and L CCS (ε LOR ) lead to the familiar random effects model whose approximately normal posterior distribution has mean µ RE ≈ i∈I µ i (σ 2 + σ 2 i ) −1 /(τ −2 + i∈I (σ 2 + σ 2 i ) −1 ) and variance σ 2 RE ≈ 1/(τ −2 + i∈I (σ 2 +σ 2 i ) −1 ) , with the same studyspecific µ i and σ 2 i as above. Uncertainty about hyperparameters τ 2 and σ 2 is reflected through prior distributions in the case study presented in Section 3. Note that the fixed effects model may be recovered in the limit as
It is a small generalization of the random effects model to describe the variation in study-specific parameters p i explicitly. Modeling them as exchangeable is equivalent (by DeFinetti's theorem) to treating them as conditionally independent identically distributed random vectors, given an overall hyperparameter θ; if the exposure effect ε can be written as a function of θ (or, more generally, if ε is conditionally independent of the { p i }, given θ) then the joint prior distribution for ε, θ, and all the { p i } can be factored as π(dε) π(dθ|ε) i∈I π(d p i |θ), giving the marginal likelihood for the exposure effect the representation
This reduces to the random effects model for θ ≡ (µ, τ, σ) and normal logistic conditional distributions π(d p i |θ); to the fixed effects model for θ ≡ ε and beta conditional distributions π(d p i c|ē |θ), π(d p i e|c |θ); and to simple pooling for θ ≡ (p ce , p cē , pc e , pcē) with unit point masses π(d p i |θ) at p i = θ.
Partially Exchangeable Combination of Evidence
Sometimes studies may be regarded as exchangeable within known groups, but the groups may differ systematically among themselves. Health care at urban and rural facilities may differ, for example, or educational performance at public and private schools or universities. The possible effects of ETS exposure in the example of Section 3 may be expected to differ across different countries for any number of reasons (competing risks, differing levels of exposure, geographically varying genetic propensities, etc.). In the simplest form the groups may themselves be treated as exchangeable, leading to a multi-stage partially exchangeable hierarchical model of the form
where g ∈ G indexes the groups and i ∈ g the studies within a group, and where each given distribution is (implicitly) conditionally independent of all parameters higher in the hierarchy. Now
For example, normal prior distributions at each stage could lead to the
for the exposure effect ε (with suitable conditional distributions for θ i , given ε i ), where σ 2 g and σ 2 i are the group-level and individual-level prior variances and τ 2 the large variance of the diffuse prior for the overall effect ε, allowing for greater homogeneity among studies within groups.
Synthesizing Heterogeneous Evidence
Studies vary in the degree to which confounding effects and possible biases have been recognized and accommodated and in the levels of similarity between their subject populations and the study population. The five synthesis methods presented in Section 1 (simple pooling, fixed and random effect models, fully and partially exchangeable hierarchical models) allow for increasing degrees of heterogeneity among studies, but they do not make use of collateral evidence about the size and impact of varying age and exposure distributions, misclassification rates, and other differences that might be expected to affect the evidence.
Several methods have been proposed for discounting evidence thought to be less reliable or to apply less directly to the questions of interest in meta-analysis, some of which were first developed to address the similar problems that arise in synthesizing the opinions of several experts (Makridakis and Winkler, 1983; Genest and Zidek, 1986; Wolpert, 1989) . These include: threshold exclusion, in which studies thought to be less applicable are simply excluded from the analysis; weighted likelihood functions; block mixtures, in which groups of studies of comparable quality or applicability are successively included in the analysis; mixtures, in which individual studies are included in the analysis with probabilities based on their relative applicability; hierarchical models, in which treatment effects are estimated separately for homogeneous groups of studies, to reveal systematic variation of apparent effects across groups. This paper investigates another alternative, intended to extract, reconcile, and synthesize information about a quantity of interest despite study variations and flaws: the systematic adjustment of the different studies within the Bayesian paradigm to accommodate (and, where possible, correct for) their differences from one another and from the intended object of study.
Adjustment
A common problem in synthesizing evidence is that of making inference about the parameter θ 0 that would govern an ideal (or paradigm) study for a particular purpose-one for the population of interest to the investigator, without misclassification or other weaknesses, on the basis of non-ideal studies whose conditions vary in important ways from the ideal. If the i th study offers direct evidence about a parameter θ i through a likelihood L i (θ i ), and if each θ i (including θ 0 ) is related to a hyperparameter θ through a known functional relation θ i = φ i (θ), then we can "adjust" the evidence from the i th study to bear directly on θ (and hence on θ 0 ) through the relation
where the arbitrary function φ i (θ) represents the value of θ i when the hyperparameter value is θ.
If the analyst studying a series of clinical trials believes that the success probability in the i th trial should be only a fraction (say, half) of the success probability θ 0 under paradigm conditions, perhaps because half of the subjects in that trial were noncompliant, then s/he might take θ 0 = φ 0 (θ) = θ and set θ i = φ i (θ) = θ/2 for that trial; of course, this choice implies that the joint prior probability distribution for the pair (θ, θ i ) is concentrated on the one-dimensional set {(θ, θ i ) : 0 ≤ θ i ≤ 1/2, θ = 2θ i } and in particular that θ i ≤ 1/2. Similarly one analyzing a series of cohort studies might use φ i (θ) = 0.9θ + 0.1θ * if 10% of the subjects were thought to be misclassified from a group with event probability θ * rather the paradigm probability
A useful generalization is the parametric adjustment model in which the adjustment function
For example, we may allow an arithmetic shift in the binomial success probability parameter θ by setting φ(θ, α i ) = θ +α i or a logistic shift by specifying
Although Eqn. (12) offers no real increase in generality over the nonparametric adjustments made in Eqn. (11), it is often easier (in our experience) to elicit expert opinion about parameter values than about transformation functions. Several examples will illustrate the parametric adjustment approach below.
If the parameter α i in Eqn. (12) is regarded as uncertain, and therefore (in the Bayesian context) random with a prior probability distribution π α i (dα i |θ), then we can form a conditional distribution for θ i given θ by averaging Eqn. (12) over the possible values of α i :
and an adjusted likelihood function
It is important not to use a noninformative prior for α i , since this ordinarily results in a constant likelihood function L Adj i (θ) lending no evidence whatsoever about θ; this is the mathematical reflection of the fact that an instrument whose bias or scale is entirely unknown can give no evidence about a measured quantity.
Specific Examples of Adjustment
In this section we will examine two specific examples of adjustments, each of the parametric or uncertain type described above, in order to illustrate the concepts.
In both case-control and cohort studies, each subject is classified three times: once when assessing eligibility, once when assessing exposure, and once when assessing outcome (case or non-case status). Thus three fundamentally different sorts of classification error may affect the analysis: eligibility violation, exposure misclassification, and case misclassification.
Anticipating the passive smoking application of Section 3, in which current or former smokers are ineligible, we denote by p i jkℓ the (true) fraction of the i th study population with case status j ∈ C ≡ {c,c} (case and non-case), exposure status k ∈ E ≡ {e,ē} (exposed and unexposed), and eligibility status ℓ ∈ S ≡ {s,s} (ineligible, i.e., ever-smoker, and eligible, i.e., neversmoker).
Interest centers on the vector θ i = (θ i ce , θ i cē , θ ī ce , θ ī cē ) of true classification probabilities {θ i j ≡ p i j|s } j∈CE of eligible (never-smoking) subjects, but through study designs and classification errors the studies give direct evidence only on the apparent classification probabilities {q i ce , q i cē , q ī ce , q ī cē } of the ostensibly-eligible subjects admitted to the study, including both those who are truly eligible and those who are not.
Eligibility Violation
Under both CCS and CHS designs, eligibility criteria may be subjective or may be based on information which is potentially inaccurate. Eligibility violations can distort evidence, particularly if violation rates differ across study arms. If the probability α ī s|js that an ineligible individual in the i th population of true classification j ∈ CE will appear to be eligible is greater than zero, or if the probability α ī s|js that an eligible individual will be recognized as eligible is less than one, then the classification probabilities {q i j } for ostensibly eligible subjects will differ from those {θ i j } for truly eligible ones:
This is a parametric adjustment θ i = φ(θ, α i ) of form Eqn. (12) for the parameter vector α i ≡ (α ī s|jℓ , p i js ) j∈CE, ℓ∈S . The experimenter may specify particular values for the eligibility misclassification probabilities and ineligiblesubject classification probabilities or, as in Eqn. (13), may reflect uncertainty about them through informative or even reference conditional prior probability distributions.
Misclassification of Exposure and Disease
In studies of both CHS and CCS design a true case might be misclassified as a non-case, or vice versa; similar errors may arise in ascertaining or recording a subject's exposure status. Thus a subject in any of the four case/exposure classes CE = {ce, cē,ce,cē} in a CHS or CCS might be misclassified in any of the other classes. Denote by α i j|k the conditional probability that a subject in study i of true case/exposure class k will be classified to class j, for each j, k ∈ CE. If the true case/exposure class probabilities for randomly-drawn subjects from the population under study in study i
, the study will give only indirect evidence about p i through likelihood function L i ( q i ) which gives direct evidence about the apparent classification probabilities q i ≡ (q i ce , q i cē , q ī ce , q ī cē ) given by
The 8 × 8 classification probability matrix α i j|k , j, k ∈ CES, would be the identity matrix for a study without classification errors, but in general must be expected to have some non-zero off-diagonal elements. If multiple classification errors are regarded as negligibly likely then α i j|k will require that up to eight misclassification probabilities be specified for each study; we illustrate this for the ETS example in Sections 3.2.3 and 3.2.4.
3 Is exposure to ETS associated with lung cancer in female nonsmokers?
Whether or not exposure to other people's tobacco smoke, or passive smoking, is harmful to health is an issue which has been widely debated over the past decade and which has broad implications in current tort and public policy decisions. An important open question remains about the impact of study quality on individual study results and on the overall body of evidence. Because lung cancer is a rare disease among never-smokers, and the possible effects under study are small, possible biases and misclassification have not been ruled out entirely as explanations for any observed increase in relative risk of deleterious health effects for those thought to be exposed to environmental tobacco smoke (ETS). Three main quality issues are commonly identified as influential in the analysis of the association between ETS exposure and lung cancer in adults who have never smoked:
1. Misclassification of ever-smokers as never-smokers. Lung cancer rates are known to be much higher among ever-smokers than among never-smokers (whether or not exposed to ETS) and ever-smokers are more likely to have smoking spouses than never-smokers (the so-called "marriage concordance"). Thus there is concern that the inclusion of active or former smokers in a study of neversmokers may lead to a systematic overstatement of the effect of ETS exposure. The debate over the effect of this issue has been lively; while some investigators such as Wu (1999) and Boffetta et al. (1998) argue that the bias is unlikely to explain the observed excess risk, others such as Lee and Forey (1999) disagree.
2. Misclassification of disease. The degree to which disease classification is verified histologically differs markedly among studies, and errors in diagnosis of lung cancer deaths based on death certificates or clinical diagnoses are widely recognized (Lee, 1992, pp. 128-129 ; Table  23 .3, p. 87). McFarlane, Feinstein, and Wells (1986) report that such misclassification is differential between active smokers and nonsmokers, but Lee (1992, p. 129) counters that these differentials have not been established for those exposed or unexposed to ETS.
3. Misclassification of exposure. The measure of exposure to ETS is most often indirect and inadequate, leading to speculation about under-or over-reporting and possible misclassification as "exposed" or "unexposed". Most studies in our dataset adopt "married to a smoker" as a surrogate measure of exposure and do not use any objective measure of exposure (such as cotinine analysis, which itself is prone to criticism since it measures only recent exposure). LeVois and Switzer (1998) suggest that variation of this misclassification rate with case status may lead to spuriously high observed relative risk.
The Environmental Protection Agency (EPA Review, 1992) and Lee (1992) provide comprehensive discussions and literature reviews of these problems for thirty-one studies available at that time, of which relevant data are available for twenty-nine. As a result, we focus on this dataset and exclude more recent studies for which such data are unavailable; in Section 5 we show that this does not limit the relevance of our conclusions to the present debate. Table 1 : Twenty-nine studies of the association between lung cancer and exposure to spousal smoking among neversmoking females (EPA Review (1992) , Tables 5-1 and 5-2, and Lee (1992) , Table 3 .13). Years refers to each study's case accrual period. Country Group and Quality Tier are described in the text.
The twenty-nine studies are summarized in Table 1 , based on the EPA Review (1992, Tables 5-1 and 5-2) and Lee (1992 , Table 3 .13), where primary references appear. Studies are categorized into "Quality Tiers" (1="best"-4="worst") by the EPA Review to reflect the study-specific level of care taken to control for various quality issues. The tier for each study was based on a sum of penalty points (ranging from −0.5, a bonus, to as high as +2.5) awarded in each of nineteen categories including eligibility (never-smoker status confirmation), explicit ETS-exposure criteria, lung cancer indication, interview type, proxy respondents, followup, design issues, and analysis issues (control of age, control of other confounders, statistical methods). Studies in the lowest (fourth) tier were regarded by the EPA Review as unsuitable for inclusion in a meta-analysis.
Study heterogeneity was acknowledged in the EPA Review by undertaking meta-analyses within but not across country groups (Greece, Hong Kong, Japan, USA, Western Europe, China). They employ a fixed-effects model, with the explicit assumption that studies within country groups are relatively homogeneous with respect to exposure, incidence, risk and other confounders (EPA Review, 1992, p. 5-31) . The impact of study quality is investigated through cumulative meta-analyses of studies in the various quality tier ranges (Tier 1, Tiers 1-2, Tiers 1-3), again within country groups. For some country groups, the overall relative risk was inflated with the addition of poorer quality studies, while for other groups the reverse occurred. For example, an estimate of 1.92 (90% CI 1.13-3.23)was reported for Tier 1-2 studies in "Greece", compared to 2.01 (1.42-2.84) based on all studies in this country group, while respective figures for the "USA" country group were 1.23 (1.04-1.42) and 1.19 (1.04-1.35).
In further analyses, the EPA Review pays specific attention to the quality issue of misclassification of active smokers as neversmokers. Unlike previous adjustments (Wald et al., 1986; NRC Committee on Passive Smoking, 1986) , in which only the overall relative risk was adjusted following analysis, the EPA Review (1992) computes "corrected" relative risk estimates for each study and the consequent bias expressed as a ratio of the corrected and uncorrected estimates (EPA Review, 1992, Table 5-8) . The underlying methodology, due to A. J. Wells and W. F. Stewart (Wells, 1990) , is based on misclassification rates found in a small number of cotinine studies and studies of discordant answers. Different (and larger) biases have been found by Lee (see discussion pp. B-3-B-4, EPA Review, 1992) using essentially the same methodology but different baseline estimates.
These observations confirm the need to account for inhomogeneity among studies and variations in study quality in a meta-analysis of these studies. In this paper we investigate alternative methods for doing this, based not on crude overall or individual study adjustment, but on integrating information about quality issues into the likelihood itself.
Exchangeable Meta-analyses
Consider simple pooling of the data into two large studies with aggregate counts (n + ce , n + cē , n + ce , n + cē ) of (1 617, 946, 3 499, 2 424) for the case control studies and (259, 108, 176 143, 147 192) for the cohort studies. With Be(1/2, 1/2) reference priors on the pairs of conditional probabilities (p e|c , p e|c ) and (p c|e , p c|ē )respectively, the posterior distributions for the exposure log odds-ratio ε LOR , with likelihood given exactly in Eqns. (2,6), are indistinguishable from the normal approximations with means and standard deviations (Eqns. (3,4) ) of 0.1690 ± 0.0487 for the case control studies and 0.6951 ± 0.1146 for the cohort studies.
Fixed and random effects analyses, using Markov chain Monte Carlo (MCMC), give overall estimates for ε LOR of 0.2072 ± 0.0471 and 0.2849 ± 0.1958, respectively. The mean exposure probabilities and mean case probabilities are similar to those from the pooled estimates, but the standard deviations are substantially larger reflecting variability among the studies. Posterior distributions of individual study log odds-ratios ε i LOR and classification probabilities (p i e|c and p i e|c for CCS, p i c|e and p i c|ē for CHS) are also available from this methodology.
A partially exchangeable random effects model can be constructed to accommodate the heterogeneity of country groups simply by employing a hierarchical prior distribution for the study-specific log odds ratios ε i , allowing for country group specific effects arising from such sources as varying exposure standards, intensities of spousal smoking, ambient air standards, etc. Results from such a model are presented in Section 4.1.
Nonexchangeable Models: Quality Adjustment
The assumption of exchangeability that is implicit in all the methods of Section 3.1 seems untenable in light of the acknowledged heterogeneity of the twenty-nine ETS studies. We now turn to implementing the new methods for synthesizing heterogeneous evidence presented in Section 2. While the studies differ in many ways, we will address the three specific examples of nonexchangeability described in Sections 2.2.1 and 2.2.2 to illustrate how these methods for adjusting likelihoods may be used to improve inference.
Each subject is classified three times: first for eligibility (neversmoking female), then for disease (lung cancer case) and for exposure (married to a smoker), in an order that depends on the study design (CCS or CHS). Altogether there are eight possible classifications, and through errors any of these could be (mis)classified as any other. In our approach we model explicitly the latent true population proportions p i jkℓ with case status j ∈ C ≡ {c,c} (case and non-case), exposure status k ∈ E ≡ {e,ē} (exposed and unexposed), and eligibility status ℓ ∈ S ≡ {s,s} (ineligible, i.e., eversmoker, and eligible, i.e., never-smoker). As in Section 2.2 we denote by α i j|k the conditional probability that a subject in study i of true case/exposure/ eligibility class k will be misclassified as class j for j, k ∈ CES, and find that Study i gives direct evidence only about (some aspects of) the apparent classification probabilities
for apparently-eligible subjects, through their individual likelihood functions
We now turn to estimating the classification probabilities α i j|k needed to make inference about the true population-based classification probabilities p i k and, through them, the true relative risk of exposure p c|es /p c|ēs , the nearly-identical exposure odds-ratio R e = p ce|s pcē |s /p cē|s pc e|s or its logarithm ε LOR = log R e .
Denote by θ i the vector θ i = {θ i ce , θ i cē , θ ī ce , θ ī cē } of true classification probabilities for eligible members of each study population (these are just the conditional classification probabilities θ i ce = p i ce|s , etc.). For the purpose of the present analysis, based on the availability of information about classification reliability in the twenty-nine studies we consider, we will make the provisional simplifying assumption that double-and triple-misclassifications are sufficiently rare to be negligible, and will only consider the possibility of at most one misclassification per subject. Under this simplification only four true classifications contribute to each apparent one, and Eqns. (14 and 15) lead to a simple expression for the probability of being classified (rightly or wrongly) in the i th study as an eligible exposed case: as the sum of the probabilities of being in fact an ineligible exposed case or of being an eligible subject who is an exposed case (correctly classified), an unexposed case (with misclassified exposure), and an exposed noncase (with misclassified case status), respectively. Similar expressions are available for q i cēs , q ī ces , and q ī cēs and, from them, the derived conditional probabilities q i e|cs , etc. that appear in the likelihood functions Eqn. (16). We now turn to the problem of identifying the parameters needed to make inference about θ i and R i e from Eqns. (16, 17): the smoking prevalences p i s , smokers' classification probabilities p i j|s , and classification probabilities α i j|k , for j, k ∈ CES.
Ever-smoking Prevalence and Classification
Estimates of the study-specific population ever-smoking prevalences p i s are given in EPA Review (1992, Table B-11).
Ever-smokers' exposure probability p i e|s = Kθ i e /(Kθ i e + θ ī e ) is available from the never-smokers' exposure probability p i e|s = θ i e = θ i ce + θ ī ce and the "marriage concordance" K ≡ (p es pēs)/(p es pē s ) reflecting the propensity of spouses to have similar smoking habits. We follow Lee (1992, pp. 158-160 and Table 3 .40), who finds K ≈ 3, although estimates as high as 5.52 have been reported in the literature (Ogden, Morgan, Heavner, Davis, and Steichen, 1997) .
Because the relative risk of lung cancer associated with active smoking in the i th study, R i s , is in general much higher than any that might be associated with passive exposure to environmental tobacco smoke (see EPA Review, 1992, Table B determine all four ever-smokers' classification probabilities p i js , j ∈ CE. Now we turn to the classification probabilities α i j|k , which will depend on how well each study addressed the difficulties of correct classification, i.e., on study quality.
First Study Quality Adjustment: Eligibility Violations
Each of the twenty-nine studies we consider requires its eligible subjects to be never-smoking females; nevertheless, for the reasons discussed at the beginning of Section 3 one must expect a small number of current or former smokers to be erroneously included in some of the studies. In this section we implement the method presented in Section 2.2.1 of adjusting the analysis to eliminate the bias and to reflect added uncertainty.
First we need to find the study-and case/exposure class-specific probabilities p 's'|s that ever-smoking individuals in the population from which the i th study sample is drawn would misrepresent their smoking status as "never-smoker." From (Lee, 1992, Table 3 .38) and in accord with other estimates (Tables 3.36 and 3.37 of Lee, 1992 and Table B -3 and the discussion on pp. B-8-B-13 of EPA Review, 1992), we estimate that about 5% of eversmokers deny ever smoking. The EPA Review and Lee consider separately the effects of misclassified regular smokers and occasional smokers; in the present analysis we do not distinguish these subclasses of ever-smokers. Lee (1992, pp. 156-157) suggests that the denial rate among cancer subjects may be a bit lower, while the EPA Review (1992, p. B-10) and (paradoxically) Lee (1992, p. 151) report evidence of "markedly higher" denial rates among lung cancer patients than among the general population; in light of this discrepancy we take them not to depend on case status (see however the discussion in Section 4.3).
There appears to be little evidence about whether or not smoking misclassification rates vary with exposure status. One might imagine that exposed subjects (i.e., those married to a smoker) might be more likely to discount any former or occasional smoking, and represent themselves as never-smokers; conversely one might imagine that unexposed subjects find more social pressure to deny former or occasional smoking. We explore sensitivity to this aspect in Section 4.3, but following the speculation of Lee (1992, p. 157) we make the provisional assumption that smoking misclassification rates do not depend on exposure status.
The EPA assigns "penalty points" A i ranging from −0.5 (a bonus) to +1.0 for each study's control of this source of bias (EPA Review, 1992, Table A-2). We take error rates to be approximately 5% for typical studies, and to double with each successive penalty point, leading to Next we need to find the study-and case status-specific probabilities p 'e'|ē and p 'ē'|e that eligible (never-smoking female) individuals would have their exposure status misclassified. A few studies report estimates of the other conditional exposure misclassification probabilities-pē |'e' , for example, the fraction of women with negligible exposure among those classified as exposed; we use Bayes' theorem to invert the conditioning below. Friedman et al. (1983) estimates that 47% of currently nonsmoking wives of smokers have negligible (less than one hour per day) exposure at home, and that 40-50% of women with nonsmoking spouses have significant ETS exposure (in the workplace, for example). In contrast, Lee (1992, p. 130) says that exposure misclassification "does not seem likely to be a major issue," and Jarvis, Feyerabend, Bryant, Hedges, and Primatesta (2001) argue that "married to a smoker" is a good surrogate for "exposed." We interpret Lee's and Jarvis et al.'s remarks as a suggestion that approximately 0-5% of women have misclassified exposure status, and use nominal values of pē |'e' = 0.25 and p e|'ē' = 0.10 as a compromise. Although Lee (1992 , Table 3 .41, p. 161) offers an estimate of 22.5% for the overall apparent exposure rate p 'e' , the empirical rates for the individual studies we consider ranged from 15% to 87% in EPA Review (1992 , Table 5 .2, pp. 5-6-5-7). Consistent with these we take a nominal value of 0.36 for p 'e' (approximately the sample median), leading to p e = p 'e' p e|'e' + p 'ē' p e|'ē' = 0.3340, pē = 1 − p e = 0.6660, p 'ē'|e = p 'ē' p e|'ē' /p e = 0.1916, and p 'e'|ē = p 'e' pē |'e' /pē = 0.1351, irrespective of case status. Thus about 14% of never-smoking women with negligible exposure to others' tobacco smoke are married to smokers and so are treated in the studies as "exposed," while almost 20% of women exposed to tobacco smoke do not have smoking spouses, but rather are exposed from other sources. The EPA assigns penalty points B i ranging from −0.5 (a bonus) to +2.5 for each study's control of this source of bias (EPA Review, 1992, Table A -2). We take these rates to apply to those studies with the least control over exposure misclassification, and again take error rates to double with each successive penalty point, leading to study-specific misclassification probabilities of 
Third Study Quality Adjustment: Misclassification of cases
The final classification error we consider is that of misclassification of lung cancer. We need to find the study-and exposure-specific probabilities p 'c'|c and p 'c'|c that eligible individuals would have their case status misclassified. The EPA Review (1992) attempts to classify studies with respect to their ability to control this source of bias through the use of histological verification. Although lung cancer misdiagnosis rates are known to differ for smokers and nonsmokers, there is no evidence or suggestion that they differ with respect to ETS exposure. Lee (1992, p. 129) cites studies in which 30-40% of lung cancers seen at autopsy are missed clinically; we take a nominal false-negative misclassification rate of 0.35, which we reduce for each study by the fraction C i of cases histologically verified (Table 5 -4 of EPA Review, 1992, and Table 3 .3 of Lee, 1992) . The fraction of false positives is less than the overall lung cancer rate, negligibly small in the present context. Thus,
A Hierarchical Prior Distribution
To complete our Bayesian model formulation it remains only to specify the joint prior distribution of the {θ i } and any features of interest, such as a measure ε of exposure effect. Since θ i can be recovered from θ i c = θ i ce + θ i cē , θ i e = θ i ce + θ ī ce , and ε i LOR by solving for θ i ce the quadratic relation
, we construct the joint distribution for θ i from that of θ i c , θ i e , and ε i . We employ a similar prior normal hierarchical distribution for the logistics log(θ i c /θ ī c ) of the cancer rates θ i c = θ i ce + θ i cē for eligible subjects in the studies, centered at conditionally-independent country-group levels which are centered in turn at an overall level with prior mean the population-wide lung cancer rate, approximately 25/10 5 , with low (0.5) precisions at each level to express very little prior opinion about never-smokers' cancer rates p i c|s .
From our earlier estimate of p 'e' ≈ 0.36 and observation that reported (apparent) exposure rates vary from 15% to 87%, we assign independent normal prior distributions with mean µ e ≈ log(.36/.64) = −0.57 and variance σ 2 e = 0.84 2 to the logistic of each θ i e , chosen to ensure that P[0.10 < θ i e < 0.75] ≈ 90%.
We assign conditionally-independent normal distribution to the studyspecific log odds-ratio ε i LOR = log(θ i ce θ ī cē /θ i cē θ ī ce ), centered at a country-groupspecific level ε g . The country-group means ε g are drawn from a normal distribution centered at an overall ε, whose distribution in turn is normal centered at zero. The relative risk for active smokers, which reportedly ranges from R i s = 1.66 to 16.3 (EPA Review, 1992, Table B -11), is believed to exceed whatever relative risk (approximately exp (ε i LOR )) may be associated with ETS exposure. Consistent with this we chose over-all, country-grouplevel, and individual-level variances σ 2 ǫ O = σ 2 ǫ G = σ 2 ǫ I = 0.33 to ensure a marginal probability P[exp(ε i LOR ) > 10] ≈ 5% with correlation of about 2/3 within each country group and about 1/3 for studies in different country groups.
Quality Adjustment Results
Posterior distributions for the quantities of interest in our Bayesian hierarchical model are not available in closed form, but are easily approximated using MCMC (Besag, Green, Higdon, and Mengersen, 1995; Gelfand and Smith, 1990; Gilks, Richardson, and Spiegelhalter, 1996; Tierney, 1994) . Full conditional distributions are available for parameters from the overall and group levels of the hierarchy, allowing us to use Gibbs sampling at those levels, while a Metropolis/Hastings approach was used at the individual study level with proposal distributions drawn from a symmetric Gaussian random walk with step sizes chosen to attain an acceptance rate of about 30% for proposed steps. The model is implemented in MatLab (The MathWorks, 2002) ; source code and data sets are available from the authors upon request. Inference is based on 2500 equally-spaced samples of nearly-independent observations from runs of ten million steps after a burn-in period of one million steps, which appear to be more than adequate to ensure MCMC convergence.
Unadjusted Results
It is apparent from Fig. 2 that the degree of association between lung cancer and ETS varies markedly across country groups.
The model described in Section 3.2 with the misclassification probabilities α i j|k all set to zero for j = k, j, k ∈ CE reduces to the partiallyexchangeable model introduced in Section 1.3, a hierarchical model in which study-specific effects ε i are taken to be similar within country groups. The posterior distributions of the study-specific quantities ε i are drawn away from their respective maximum likelihood estimates (MLE's)ε i = log(n ce ncē/n cē nc e ) (or posterior meansε i under independent reference prior distributions) toward group level quantities ε g , for i ∈ g, whose distributions in turn are drawn together toward an overall level ε. This shrinkage effect, more pronounced for smaller studies than for larger ones, is an expression of the regression effect. . Note the wide variability of the posterior distribution for ε, shown as a probability density function. Fig. 4 shows the posterior distribution for the overall exposure odds ratio R e ≡ exp(ε) with no adjustment (thick solid line), overlaid with the posterior distributions from naïve pooling of CCS and CHS studies (dash-dot and dashed thin lines), and from the fixed-effect and random-effect models of Section 3.1 (dash-dot and dashed thick lines). Individual study MLE's are shown on the horizontal axis as downward tickmarks (for CCS) and upward ones (for CHS), with lengths proportional to precision (i.e., larger studies exerting more influence on the overall posterior distributions are indicated by larger symbols). Note the larger variability of the hierarchical Table 5-7) for Greece, Hong Kong, Japan, U.S.A., Western Europe, and China. random-effects model when compared with the simple pooling and fixedeffects models, more accurately reflecting all the sources of variability and uncertainty, and its general similarity with the (still more widely-dispersed) posterior density for the unadjusted model.
Adjusting Study Evidence for Quality Variations
Studies differ in their degrees of effort and levels of success in addressing each of the three types of misclassification discussed in Section 3. We investigate the impact of adjustment for misclassification in two stages, first for eligibility and then for exposure and case status. The marriage concordance (Lee, 1992 , pp. 158-160) led many investigators (e.g., Lee (1992, pp. 143-145) and the EPA Review (1992, §5.2.2, pp. 5-22-5-25 and Table 5-8)) to expect that disproportionately many exposed subjects in case controlled studies would be ever-smokers misclassified as never-smokers, creating a bias elevating the apparent association between lung cancer and ETS. We thus anticipated that properly adjusting for eligibility misclassification would reduce this bias and show a smaller degree of association. Fig. 5 shows the posterior means for the study-specific exposure odds ratios E[R i e ≡ exp(ε i )] within the unadjusted model (as in Fig. 4) on the left (A), adjusted for eligibility in the middle (B), and adjusted for all misclassifications on the right (C). Evidently, our adjustment for eligibility misclassification lead to a very slight reduction in apparent association between ETS and lung cancer (the mean dropped from 1.301 to 1.291), while subsequent adjustments for case and exposure misclassification lead to slight reductions for some studies and slight increases for others, and generally to slight increase in mean with a much larger variability (95% CI widened and rose from [0.800, 2.066] to [0.845, 2.224]), contrary to our anticipation of a consistent downward trend but consistent with an earlier analysis (EPA Review, 1992, Table B-11) and the recent observation of Boffetta (2002) that several sources of bias may lead to both overestimation and underestimation of true association.
A Tale of Two Studies
We illustrate the effects of adjustment by examining how it affects the evidence from two studies, a Tier 4 CCS study (#4, CHAN) from country group HK and a Tier 2 CHS study (#28, HIRA) from country group JP (quality tiers and country groups, assigned by the EPA Review, 1992, are reproduced in Table 1 ). Case-control studies offer evidence about the popu- lation exposure rate θ i e but, due to their design, give no evidence about the population case rate θ i c ; conversely cohort studies offer evidence about θ i c but not θ i e . Thus the posterior distributions for these quantities differ markedly for the two designs. Data proportions (n c /n + , n e /n + ) are indicated in Fig. 6 by solid and dashed vertical lines, respectively. Posterior distributions for the quantities not illuminated by the data (θ i c for CCS, θ i e for CHS) remain close to their prior distributions (also shown in Fig. 6 as unshaded curves) .
Study evidence bears directly on the two apparent conditional probabilities that govern the arms of the study-q i e|c , q i e|c for CCS, q i c|e , q i c|ē for CHS. Fig. 7 shows the likelihood functions for q c|e and q c|ē for the arms of a CHS study #28 (HIRA) as a dotted line, along with their posterior distributions in our hierarchical model (dashed lines) and those of the study-specific true classification probabilities for eligible subjects, θ i c|e , θ i c|ē (solid lines). Notice that the likelihood (dotted curve), representing a face-value acceptance of the immediate evidence without considering possible eligibility and classification errors, is far narrower than the other curves which reflect the possibility that (through misclassification) the study's sample misrepresents its population, and that the apparent probabilities q i lie closer to the immediate evidence of the likelihoods than do the study-specific estimates of the population-based classification probabilities θ i . Figures for CCS's and CHS's are similar; the plot for the q i posterior distributions are broader than their likelihoods but centered at the same location, while plots for the θ i 's are very similar to those for the q i 's for studies with low misclassification rates (where adjustment for possible classification errors has little effect) and are often shifted for studies with higher misclassification rates (where adjustment effects are more pronounced).
Posterior distributions for the study-specific log odds ratios ε i LOR are drawn toward the country-group mean for both types of studies; thus in Fig. 8 the "unadjusted" posterior distribution (solid line) is shifted a bit to the right from the likelihood function (dashed line) in the direction of the group mean. Unexpectedly, adjustment for eligibility violations (dotted curves) makes little net change for either of these studies; adjustment for misclassification of case and exposure status (dashed curves) makes a slightly larger impact, broadening the CCS study slightly and shifting the CHS study a bit to the right. 
Sensitivity
The process of building Bayesian models is really a dynamic one. There is no hope of modelling explicitly everything that is uncertain and that affects inference to any degree, however small. The decisions about exactly which features to model as "uncertain," requiring the specification of a conditional prior distribution and increasing the dimension of the subsequent posterior integration, are based on judgement or evidence about how sensitive our posterior inference is to their inclusion.
In Section 3.2 we described our approach to finding suitable estimates for the many quantities needed to adjust the twenty-nine studies we consider and make them more nearly comparable-the smoking prevalences p i s , smokers' classification probabilities p i j|s , the misclassification rates α i j|k for j = k, j, k ∈ CES, and the means and precisions needed in our three-level hierarchical logistic normal model for (ε i , θ i c , θ i e ). The ETS case study we present here is unusual in that so much hard work has been done by others (particularly by P. N. Lee and by the EPA Review panel) at assessing and quantifying population and study features in copious detail. Some of these quantities are known with less certainty than others; in this section we ex- Figure 7 : Likelihood functions and posterior probabilities for cancer case probabilities within "exposed" and "unexposed" arms of a CHS. plore sensitivity to some of the choices we made-smoking prevalances and some misclassification rates. In Section 3.2.3 we based estimates of the typical exposure misclassification rates p 'ē'|e ≈ 0.1916 and p 'e'|ē ≈ 0.1351 and true exposure rate of p e ≈ 0.3340 on nominal literature values of p 'e' ≈ 0.36 for the overall apparent exposure rate and pē |'e' ≈ 0.25 and p e|'ē' ≈ 0.10 for the true exposure misclassification probabilities for those classified as exposed and unexposed, respectively; each of these nominal literature values was a compromise from widely varying literature estimates. If instead we were to take literally the apparent exposure estimate p 'e' ≈ 0.225 from (Lee, 1992, Table 3 .41, p. 161) (well below the reported exposure rates among our studies) and the misclassification rate estimates of pē |'e' ≈ 0.47, p e|'ē' ≈ 0.40-0.45 from Friedman et al. (1983) (ignoring the contrary evidence of Lee (1992, p. 130) and Jarvis et al. (2001) ) we would find the far higher error probabilities p 'ē'|e ≈ 0.7474 and p 'e'|ē ≈ 0.1970 and higher true exposure rate of p e ≈ 0.4678.
This would distort our inference about quantities of interest such as the overall odds ratio R e = exp(ε LOR ); point estimates would rise from the value R e ≈ 1.374 we find in the present analysis to as high as 1.87 with these (untenable, as we will see) values. CHS study #28 (HIRA) reports n ce = 163 cases among n e = 69645 apparently exposed subjects, and n cē = 37 cases among n c = 21895 apparently unexposed ones. It is impossible to reconcile these with error rates as high as p 'ē'|e ≈ 0.7474, p 'e'|ē ≈ 0.1970; the numbers m j of subjects with true case/exposure classification j ∈ CE are related to those of apparent classification k ∈ CE by a linear relation n j = α j|k m j , whose solutionm for these error probabilities and casecounts would givem ce ≈ 318.2 cases amongm e ≈ 57309 truly exposed subjects, about double the reported rate, andm cē ≈ −10 cases among thê m e ≈ 10657 truly unexposed ones, an obvious impossibility.
In Section 3.2.2 we recounted the contradictory evidence and published opinion about whether and how eligibility misclassification rates might vary with case and exposure status. The results presented in Fig. 5 are based on the assumption that eligibility misclassification rates do not vary with status (see Eqn. (19)). In a sensitivity analysis we explored the consequences of changing this assumption, taking the eligibility misclassification rates αs |js to vary with case/exposure status j ∈ CE. A surprising sensitivity was revealed, particularly to the possibility of rates that vary with exposure status.
Under the hypothetical assumption of no true association between lung cancer and ETS, R e = 1, a wide variety of eligibility misclassifications will all lead to an apparent positive associationR e > 1 (Tweedie et al., 1995) . It is perhaps surprising that, for true values R e > 1, differential eligibility misclassification can distort the evidence in either direction. We can illustrate the point with an artificial example.
The top portion of Fig. 9 illustrates the effect of various possibilities about eligibility misclassification rates, for a true odds ratio of R e = 1 (i.e., if ETS and lung cancer were unrelated); each of the curves lies above the horizontal line at R e ≡ 1, indicating that in all cases the effect of misclassification is to inflate the apparent association. However, if the true odds ratio were R e ≈ 1.3, a value consistent with many of the estimates reported in the literature, the bottom portion of Fig. 9 illustrates that if unexposed subjects were to have double the eligibility misclassification rate of exposed ones (perhaps from social pressure to deny smoking), then the apparent association would fall fromR e ≈ 1.30 down toR e ≈ 1.22 as the exposedsubject eligibility misclassification rate rises from αs |ce = 0 to 0.10 (dashed line), distorting the apparent relative risk downwards. Conversely if exposed subjects were to have half the eligibility misclassification rate of unexposed ones (perhaps because their occasional smoking seems insignificant), then the apparent association would rise fromR e ≈ 1.30 up to the inflated figure αs |cē = αs |ce αs |cē = αs |ce αs |cē = αs |ce · 2 αs |cē = αs |ce · 2 αs |cē = αs |ce / 2 αs |cē = αs |ce / 2 αs |ce = αs |ce · 2 αs |ce = αs |ce / 2 Figure 9 : Sensitivity of odds ratio inference to exposure-specific eligibility misclassification rates. ofR e ≈ 1.63 (dotted line in Fig. 9 ). Equal deception rates also show an inflation in apparent association (dash-dot line).
Evidently risk estimates are quite sensitive to the very uncertain feature of possible variation of smoking denial rates with exposure status. Uncertainty about these rates poses an obstacle not only to synthesizing evidence from several studies, but even to interpreting the evidence of a single study. Our observed sensitivity of the model to "apparently innocuous assumptions" is supported by the findings of Higgins and Spiegelhalter (2002) in a comparison of the inferences arising from a meta-analysis and those from a mega-trial.
It is of course possible to reflect uncertainty about the deception rates within our modeling framework by adding a new level of model hierarchy and introducing a joint prior distribution for the deception rates {α ī s|js } and misclassification rates {α i j|k } as in Eqn. (13), but we do not pursue that further here.
Discussion
The hierarchical Bayesian approach described in this paper provides a new flexibility in meta-analysis by facilitating the formal adjustment of evidence for variations in important factors such as quality and design at the studyspecific level. The non-exchangeable models advocated here accommodate such study-specific heterogeneity through careful specification of joint prior distributions for study-specific parameters that adjust directly the evidence from each study's likelihood. This coherent, likelihood-based approach is arguably superior to alternative approaches such as naïvely combining reported values without any adjustment, discounting or excluding some or all studies on the basis of perceived problems of quality or study design, or invoking (often unsupportable) exchangeability assumptions in more traditional random effects models or making often arbitrary adjustments at a broad scale. Note that the need for adjustment and the size of its effect do not diminish for large studies-a study with a high misclassification rate will give distorted or biased evidence, no matter how large its sample size.
Other methods for combining the evidence from disparate studies have been suggested in the literature. For example, Thompson and Sharp (1999) propose weighted regression in place of a hierarchical model for obtaining estimates of effect size for different covariate values. A multivariate metaregression analogue of this approach could be developed for the ETS case study (as suggested by a referee). Alternatively, the problem could be cast in the form of a measurement error model (Cheng and Van Ness, 1999) , in which each study's results are treated as measurements (with error) of model parameters. A related approach is adopted by Aitchison (1977 Aitchison ( , 1979 , who uses inter-clinic calibration data to combine studies from multiple clinics that differ in their methods of measurement of diagnostic features.
The unadjusted estimates in the present meta-analyses of the relative risk of lung cancer associated with ETS exposure are consistent with the results of other published meta-analyses (Wald, Nanchahal, Thompson, and Cuckle, 1986; NRC Committee on Passive Smoking, 1986; Tweedie and Mengersen, 1992; EPA Review, 1992; Lee, 1992; OSHA, 1994; Hackshaw, Law, and Wald, 1997; Zhong, Goldberg, Parent, and Hanley, 2000; Boffetta, 2002) . For example, Hackshaw et al. (1997) estimate R e ≈ 1.24 (1.13-1.36), based on 37 studies; Zhong et al. (2000) report R e ≈ 1.20 (1.12-1.29) based on 35 case control and five cohort studies; Boffetta et al. (1998) report R e ≈ 1.16 (0.93-1.44) in a multi-center European study; and Boffetta (2002) finds an overall relative risk of R e ≈ 1.25 (1.15-1.37) based on 51 relevant studies comprising 7369 observed cases of lung cancer. A very recent reanalysis by Enstrom and Kabat (2003) of the large American Cancer Society's first cancer prevention study has reported a point estimate less than unity and thus an overall null effect. Moreover the adjusted point estimates are in broad agreement with those that adjust using less formal methods,although our 95% credible interval (0.845-2.224) is somewhat wider because our hierarchical Bayesian approach is more faithful in representing multiple sources of uncertainty. It is clear that the dataset considered here, despite its age, provides a vehicle for making relevant contributions to the current ongoing debate about the association between ETS and lung cancer.
Of course sources of bias other than study quality may influence the results of this or any other meta-analysis. For example, a topical issue is the potential influence of publication bias, that is, the differential tendency to publish small studies that show a positive (whether or not significant) effect but not to publish small studies showing a negligible or negative effect. An attempt to 'control' the quality of included studies by restricting meta-analysis to published studies may exacerbate the effects of publication bias, leading to spuriously high estimates of overall relative risk. Controversy surrounds the potential influence of this source of bias for the issue examined in this paper. Lee (1992, p. 166) states that 'overall, it appears that some publication bias has occurred, and that it can explain a part, but by no means all, of the observed association. ' Givens et al. (1997) propose a data-augmentation method to simulate the results of unobserved studies within an hierarchical model and conclude that the overall association between ETS and lung cancer in non-smoking women may be overstated by around 30%, in both US and global studies. A trim-and-fill funnel plot approach taken by Duvall and Tweedie (2000a, b) led to a similar conclusion of overstatement. Copas and Shi (2000) similarly argued that the overall excess risk of 24% reported by Hackshaw et al. (1997) could be reduced to 15% after accounting for this form of bias. The ensuing debate over these papers (see the corresponding discussions) has refuted these claims strongly, arguing that they overestimate the number of missing studies and their impact.
Other quality issues not considered in the present analysis include confounding with dietary factors (suggested by Boffetta et al. (1998) but later disputed by Brennan et al. (2000) ), genetic susceptibility (Bennett et al., 1999) , and variable length of exposure leading to bias through right-censoring.
Our approach offers a number of advantages over earlier ones. First, it requires very strict and explicit identification of the factors for which adjustment is to be made. This necessitates a strong audit trail of the rationale behind the proposed adjustment, the source and degree of detail of the evidence at a study-specific level and an acknowledgment of the uncertainty of the proposed adjustment. These in turn guide the expression of the adjustment in the model and the level of the hierarchy to which it will be applied.
A second advantage afforded by the proposed approach is an introspection about the impact of the claimed evidence, at both study-specific and global levels. This was illustrated in the ETS analysis through the sensitivity assessments of Section 4.3. The model naturally afforded a formal assessment of the surprising sensitivity to differential case and exposure misclassification and the inapplicability at the study-specific level of some published estimates of exposure misclassification. Importantly, a consequence of these requirements for detailed evidence from trusted sources and an understanding of the implications of the choice of evidence is a healthy respect for meta-analysis in general and a careful regard for interpretations made on the basis of it.
Care must be taken in interpreting published estimates of error rates. Usually investigators report estimates of the fraction of the sample that is misclassified, e.g., report P[s | 's'], when likelihood-based adjustment methods like ours require the fraction of the population that is liable to misclassification, e.g., P['s' | s]. These differ whenever P[s] = P['s'], as in our example (smokers deny smoking far more often than never-smokers claim to smoke). In Section 3.2.3 we illustrate how to calculate the needed quantities from those usually available.
A third advantage is that we are able to make probabilistic statements impossible under the earlier approach followed in (Lee, 1992; EPA Review, 1992) . We can find posterior distributions of any quantities of interest (not just model parameters, but arbitrary functions of them) at any hierarchy level of the model, or can find various point estimates (means, medians, etc.) and statements of associated uncertainty (credible intervals, posterior standard deviations, etc.). In the ETS analysis, for example, the prior probability of any positive association between lung cancer and ETS is P[ε > 0] = 1/2; upon shrinking study evidence toward country groups (but not yet adjusting for quality), this rises to P[ε > 0] = 0.851; upon adjusting for eligibility violations it rises imperceptibly to P[ε > 0] = 0.856; and with all quality adjustments it rises to P[ε > 0] = 0.907. Cancer odds are unlikely to increase by as much as a factor of two, however; there is over 90% chance that the relative risk associated of cancer for never-smoking women married to smokers is less than twice that of never-smoking women married to nonsmokers. Thus on the basis of this analysis the case for an association between ETS and lung cancer is strong but evidence of a sizeable effect is not compelling.
A fourth advantage is that we can use collateral information at whatever is the most appropriate level-individual study, country group, or overall, and that our MCMC-based implementation makes it easy to make detailed probabilistic statements about features of inferential importance at any of these levels. Multiple comparisons that are largely inaccessible under other paradigms are achieved here in a straightforward manner. For example, in the ETS model without adjustment for misclassification, P[ε US = max g∈G {ε g }] = 0.11, whereas P[ε GR = max g∈G {ε g }] = 0.40, and P[ε GR > ε US ] = 0.69.
The fifth advantage is the approach's simplicity and flexibility. The number and nature of levels of hierarchy can be tailored to the needs of a particular problem, and adjustment (like those we applied for classification errors) may be imposed at any level(s) of that hierarchy. The top level θ of the hierarchy can be any hyperparameter conditional on which the studyspecific parameters {θ i } are independent; in some cases this may be the parameter θ 0 that would govern an "ideal" trial for a particular investigator's purposes, as in Section 2.1, but in other cases it may be more abstract.
Our estimates of misclassification rates (leading in our linear parametric adjustment approach to the classification matrix α) are an easily interpreted and public part of our analysis; investigators who disagree with our choices (for example, those who disapprove of our simplifying assumption of no multiple misclassifications) are free to substitute their own and explore the same evidence in the light of their different assumptions.
Finally, the type of adjustment itself is also flexible, in that one is able to parameterize whatever variations exist among studies under study and express uncertainty about those variations (perhaps in a non-exchangeable fashion) in the form of joint prior distributions. The computational feasibility of the MCMC algorithm that implements the approach, which in the ETS example translated into the ability to complete million-step runs in under half an hour on a laptop computer, allows the investigator to explore such modifications interactively, with appropriate assessment of convergence and sensitivity. This interactive exploratory model-building with complete representation of uncertainty is a powerful tool for interpreting and synthesizing evidence from multiple sources.
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